US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Prospect Capital Corp

25.06

+0.0000

Volume:- -

Turnover:319.71K

Market Cap:9.22B

PE:68.17

High:25.06

Open:25.06

Low:25.06

Close:25.06

Loading ...

Overview Company News Filings

GENFIT Announces Completion of Non-dilutive Royalty Financing Agreement with HCRx and Results of Repurchase Offer to 2025 OCEANEs holders

Planet Labs PBC Releases Images From Pelican-2

Planet Labs PBC options imply 9.2% move in share price post-earnings

GILD Stock Trading Close to Its 52-Week High: Should You Buy or Sell?

Why Planet Labs PBC (PL) Is Declining This Week?

With A 39% Price Drop For Planet Labs PBC (NYSE:PL) You'll Still Get What You Pay For

Simply Wall St.

Press Release: Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs

Planet Labs PBC (PL): Game-Changing AI Partnership with Anthropic Real-Time Satellite Insights!

Zevia PBC (ZVIA): the Best Vegan Stock to Buy According to Analysts

Companies Like Planet Labs PBC (NYSE:PL) Are In A Position To Invest In Growth

Simply Wall St.

Zevia PBC: Hold Rating Amid Solid Q4 Results and Uncertain 2025 Outlook

Tharimmune Announces Positive Target Engagement with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick Technology

ACCESS Newswire

Zevia PBC Is Maintained at Market Perform by Telsey Advisory Group

Zevia PBC (ZVIA) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Expansion

Q4 2024 Zevia PBC Earnings Call

Thomson Reuters StreetEvents

Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PBC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBC\",,,,,undefined,":{"symbol":"PBC","market":"US","secType":"STK","nameCN":"Prospect Capital Corp","latestPrice":25.06,"timestamp":1640811600000,"preClose":25.06,"halted":4,"volume":0,"delay":0,"floatShares":0,"shares":367817926,"eps":0.367626,"marketStatus":"Delisted","change":0,"latestTime":"04-01 17:17:33 EDT","open":25.06,"high":25.06,"low":25.06,"amount":319705.1613,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.367626,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1743552000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":25.06,"dividendRate":0.028731,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBC\",,,,,undefined,":{"symbol":"PBC","floatShares":0,"roa":"4.83%","roe":"4.16%","lyrEps":0.394789,"shares":367817926,"dividePrice":0.72,"high":25.06,"amplitude":0,"preClose":25.06,"low":25.06,"week52Low":25,"pbRate":"2.90","week52High":26.49,"institutionHeld":0,"latestPrice":25.06,"eps":0.367626,"divideRate":0.028731,"volume":0,"delay":0,"ttmEps":0.367626,"open":25.06},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBC\",pageSize:16,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521494099","title":"GENFIT Announces Completion of Non-dilutive Royalty Financing Agreement with HCRx and Results of Repurchase Offer to 2025 OCEANEs holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2521494099","media":"GlobeNewswire","labels":["buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521494099?lang=en_us&edition=fundamental","pubTime":"2025-03-21 05:10","pubTimestamp":1742505000,"startTime":"0","endTime":"0","summary":"GENFIT completes a royalty financing of up to 185 million with HCRx after unanimous OCEANE bondholder approval, triggering a 130 million upfront payment with potential for an additional 55 million upon achieving near-term milestones. Non-dilutive financing extends cash runway beyond 2027 and supports GENFIT’s R&D efforts. Financing strengthens GENFIT's ACLF pipeline development and commitment to transformative therapies. GENFIT to use 61.66 million to repurchase 1,882,891 2025 OCEANEs after exercise by certain bondholders of their put option, reducing the nominal amount of GENFIT’s convertible debt to 586 thousand. Pascal Prigent, CEO of GENFIT, commented: “We are very pleased that we have now successfully closed this transaction. It gives us financial visibility beyond 2027 and will enable us to pursue development of all the programs in our very rich pipeline. We also believe it is positive for our shareholders as we have lifted our convertible debt burden without any dilution.”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genfit-announces-completion-non-dilutive-211000503.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CCA","GNFT","PBC","GNFTF","BK4139","USA"],"gpt_icon":0},{"id":"2521491621","title":"Planet Labs PBC Releases Images From Pelican-2","url":"https://stock-news.laohu8.com/highlight/detail?id=2521491621","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521491621?lang=en_us&edition=fundamental","pubTime":"2025-03-21 04:08","pubTimestamp":1742501280,"startTime":"0","endTime":"0","summary":"Pelican-2 First Light imagery taken over the Port of Laem Chabang, Thailand from March 12, 2025. The port and its surroundings can be seen in one of Planet’s largest swaths captured to date.Pelican-2 First Light imagery taken over the Port of Laem Chabang, Thailand from March 12, 2025. A detailed view of the port shows the fine detail of the ships, containers, and associated infrastructure.\"I’m deeply proud of the Pelican team that made this achievement possible. The data we’re getting back from the early stages of our Pelican-2 satellite proves the technical maturity of this new system, and is a testament to their hard work,\" said Brian Lewis, Mission Director, Pelican. \"Pelican’s ability to reduce downlink latency while improving our image quality and capabilities will help ensure our customers and partners have a seamless tasking experience and can consistently monitor critical changes happening on the ground. This is just the beginning of the high-resolution imagery we pl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/planet-labs-pbc-releases-images-200800943.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVDY","2NVD.UK","LU1935042991.SGD","LU1127390331.HKD","NVIW.SI","IE00B19Z8X17.USD","NVDS","LU2083900584.USD","IE00BN29S564.USD","LU0640476718.USD","LU0029864427.USD","LU2462157665.USD","IE00B5949003.HKD","LU0823414478.USD","PL","LU1674673428.USD","LU2250418816.HKD","LU2505996681.GBP","LU0154236417.USD","LU1116320901.HKD","IE00BQXX3C00.GBP","BK4532","LU0354030438.USD","LU1814569148.SGD","NVD3.UK","LU1712237335.SGD","NVDS.UK","IE00BWXC8680.SGD","LU0289960550.SGD","LU0107464264.USD","NVDU","LU0323591593.USD","LU0128525929.USD","IE00BMPRXR70.SGD","SG9999015358.SGD","LU2065171311.SGD","SNVD.UK","NVD","3NVD.UK","LU0238689110.USD","NVDD","IE00B7KXQ091.USD","LU2471134879.HKD","NVD2.UK","BK4608","LU0820561818.USD","PBC"],"gpt_icon":1},{"id":"2521938604","title":"Planet Labs PBC options imply 9.2% move in share price post-earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2521938604","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521938604?lang=en_us&edition=fundamental","pubTime":"2025-03-21 02:50","pubTimestamp":1742496625,"startTime":"0","endTime":"0","summary":"Pre-earnings options volume in Planet Labs (PL) PBC is 1.3x normal with calls leading puts 9:5. Implied volatility suggests the market is anticipat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/planet-labs-pbc-options-imply-9-2-move-in-share-price-post-earnings-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/planet-labs-pbc-options-imply-9-2-move-in-share-price-post-earnings-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBC"],"gpt_icon":0},{"id":"2520686466","title":"GILD Stock Trading Close to Its 52-Week High: Should You Buy or Sell?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520686466","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520686466?lang=en_us&edition=fundamental","pubTime":"2025-03-18 03:00","pubTimestamp":1742238000,"startTime":"0","endTime":"0","summary":"Gilead Sciences, Inc. GILD hit a 52-week high of $119.96 on March 10. The stock is currently trading at $111.44.Shares have also gained 5.5% in the past month compared with the industry’s growth of 1.2%. The stock has outperformed the sector and the S&P 500 Index in this timeframe. Positive data readouts and encouraging pipeline progress have boosted investors’ sentiment.Gilead has a market-leading portfolio of HIV treatments. The company’s consistent efforts to develop additional innovative HIV treatments are being appreciated by investors.GILD’s HIV franchise sales have consistently grown in the last three years, propelling the top line.With a market share of more than 50% in the United States at the end of the fourth quarter, its flagship HIV therapy Biktarvy continues to fuel sales.The candidate was approved under the brand name Livdelzi. In March 2024, GILD acquired CymaBay Therapeutics Inc. for $4.3 bil","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gild-stock-trading-close-52-190000459.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0965508806.USD","SGXZ57979304.SGD","BK4568","GSK","IE0002270589.USD","IE0009355771.USD","LU0109394709.USD","LU2089984988.USD","LU0058720904.USD","SG9999014575.USD","BK4007","PBC","IE00B19Z3B42.SGD","LU0266013472.USD","IE00B7SZLL34.SGD","IE00B3T34201.USD","LU0861579265.USD","LU1066053197.SGD","LU1929549753.HKD","LU0203347892.USD","IE00B4R5TH58.HKD","LU1983299246.USD","SG9999001440.SGD","GSK.UK","LU0234570918.USD","LU1430594728.SGD","LU1585245621.USD","LU1974910355.USD","SG9999015358.SGD","GILD","LU1829250122.USD","LU1061106388.HKD","LU1571399168.USD","MRK","BK4139","LU1989771016.USD","IE00BLSP4452.SGD","LU0265550359.USD","LU2361044949.HKD","LU0238689110.USD","IE00BFTCPJ56.SGD","SG9999001176.SGD","LU2461242641.AUD","IE000M9KFDE8.USD","LU0122379950.USD","LU0965509283.SGD","LU1917777945.USD","IE00BBT3K403.USD","LU1699723380.USD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2518723400","title":"Why Planet Labs PBC (PL) Is Declining This Week?","url":"https://stock-news.laohu8.com/highlight/detail?id=2518723400","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518723400?lang=en_us&edition=fundamental","pubTime":"2025-03-11 22:35","pubTimestamp":1741703707,"startTime":"0","endTime":"0","summary":"We recently published a list of Why These Defense Stocks Are Declining This Week. In this article, we are going to take a look at where Planet Labs PBC  stands against other defense stocks that are declining this week.European defense stocks have rallied this year as governments faced pressures to increase military spending. During the week of March 3, several stocks registered double-digit growth, with some even recording all-time highs. Investor sentiment picked up after the European Summit in London, where leaders from the EU and NATO met to express their support for Ukraine.The United States has repeatedly called for Europe to spend more on defense, stressing it could no longer foot the bill. EU leaders met in Brussels on Thursday to discuss the ‘ReArm Europe Plan’, which will allow the bloc to mobilize funds up to $860 million through bonds and relaxed rules on borrowing and spending.Let’s now head over to the list of defense stocks that are declining this week. Please note that t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-planet-labs-pbc-pl-143507162.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PBC","PL","BK4123"],"gpt_icon":1},{"id":"2518720250","title":"With A 39% Price Drop For Planet Labs PBC (NYSE:PL) You'll Still Get What You Pay For","url":"https://stock-news.laohu8.com/highlight/detail?id=2518720250","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518720250?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:40","pubTimestamp":1741696806,"startTime":"0","endTime":"0","summary":"Planet Labs PBC ( NYSE:PL ) shares have had a horrible month, losing 39% after a relatively good period beforehand...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9612012-choice2-main-header/1585186803878","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9612012-choice2-main-header/1585186803878"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/commercial-services/nyse-pl/planet-labs-pbc/news/with-a-39-price-drop-for-planet-labs-pbc-nysepl-youll-still","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4123","PL","PBC","NYSE"],"gpt_icon":1},{"id":"2518778574","title":"Press Release: Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs","url":"https://stock-news.laohu8.com/highlight/detail?id=2518778574","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518778574?lang=en_us&edition=fundamental","pubTime":"2025-03-11 05:10","pubTimestamp":1741641000,"startTime":"0","endTime":"0","summary":"Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs. -- Closing of Royalty Financing and receipt of first EUR130 million. -- Upon closing of the Royalty Financing, GENFIT will implement the. Repurchase of the 2025 OCEANEs and pay the Consent Fee. The terms and conditions of the 2025 OCEANEs contained a negative pledge clause which limited the ability of the Company to grant security interests to its creditors upon its present or future assets or revenues. The closing of the royalty financing with HCRx , which was signed and announced by GENFIT on January 30, 2025, was subject to approval of 2025 OCEANEs bondholders of an amendment to this negative pledge clause, allowing for the grant of the security interest contemplated in the Royalty Financing documentation, and other customary closing conditions.The result of the vote resolution by resolution is available on the website of the Company .The Company also undertook, s","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBC","R","USA","GNFT","CCA","BK4022","GNFTF","BK4232","BK4139"],"gpt_icon":0},{"id":"2518798572","title":"Planet Labs PBC (PL): Game-Changing AI Partnership with Anthropic Real-Time Satellite Insights!","url":"https://stock-news.laohu8.com/highlight/detail?id=2518798572","media":"Insider Monkey","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518798572?lang=en_us&edition=fundamental","pubTime":"2025-03-10 22:05","pubTimestamp":1741615531,"startTime":"0","endTime":"0","summary":"We recently published a list of Top 9 Trending AI News Investors Probably Missed. In this article, we are going to take a look at where Planet Labs PBC  stands against other top trending AI news investors probably missed.Battle lines on artificial intelligence supremacy and dominance have been drawn. Fresh from touting the success of DeepSeek on the development of cost-effective AI models, China has made it clear it won’t sit back and play second fiddle to US dominance on AI innovations.“This infrastructure will secure American leadership in AI, create hundreds of thousands of American jobs, and generate massive economic benefits for the entire world. This project will not only support the re-industrialization of the United States but also provide a strategic capability to protect the national security of America and its allies,” OpenAI said in a statement about the Stargate Project.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/planet-labs-pbc-pl-game-140531780.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PBC","BK4123","PL"],"gpt_icon":1},{"id":"2517445594","title":"Zevia PBC (ZVIA): the Best Vegan Stock to Buy According to Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2517445594","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517445594?lang=en_us&edition=fundamental","pubTime":"2025-03-08 00:55","pubTimestamp":1741366525,"startTime":"0","endTime":"0","summary":"We recently published a list of the 10 Best Vegan Stocks to Buy According to Analysts. In this article, we are going to take a look at where Zevia PBC  stands against the other best vegan stocks to buy according to analysts.The primary reason behind this growth is the continually growing awareness regarding the benefits of a vegan diet. Concerns about animal cruelty and animal health are supporting the growth of this industry, causing people to shift from an animal-based to a plant-based and vegan diet. Grand View Research reported that Grubhub, a major online food delivery application, accounted for the upsurge of 17% in overall vegan food deliveries in 2021.“This increase likely reflected a mix of factors, including sticky inflation but also the recent jump in prices of key household staples like eggs and the expected impact of tariffs. There was a sharp increase in the mentions of trade and tariffs, back to a level unseen since 2019. Most notably, co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zevia-pbc-zvia-best-vegan-165525524.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4177","BK4539","PBC","ZVIA"],"gpt_icon":0},{"id":"2517190519","title":"Companies Like Planet Labs PBC (NYSE:PL) Are In A Position To Invest In Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2517190519","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517190519?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:40","pubTimestamp":1741178423,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt.Given this risk, we thought we'd take a look at whether Planet Labs PBC  shareholders should be worried about its cash burn. For the purpose of this article, we'll define cash burn as the amount of cash the company is spending each year to fund its growth . The first step is to compare its cash burn with its cash reserves, to give us its 'cash runway'.When Might Planet Labs PBC Run Out Of Money?So, Should We Worry About Planet Labs PBC's Cash Burn?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/companies-planet-labs-pbc-nyse-124023335.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NYSE","PBC","PL","BK4123"],"gpt_icon":1},{"id":"2517135601","title":"Zevia PBC: Hold Rating Amid Solid Q4 Results and Uncertain 2025 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2517135601","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517135601?lang=en_us&edition=fundamental","pubTime":"2025-03-05 00:45","pubTimestamp":1741106723,"startTime":"0","endTime":"0","summary":"Zevia PBC (ZVIA – Research Report), the Consumer Defensive sector company, was revisited by a Wall Street analyst today. Analyst Dara Mohsenian fro...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/zevia-pbc-hold-rating-amid-solid-q4-results-and-uncertain-2025-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/zevia-pbc-hold-rating-amid-solid-q4-results-and-uncertain-2025-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBC","ZVIA"],"gpt_icon":0},{"id":"2516678211","title":"Tharimmune Announces Positive Target Engagement with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2516678211","media":"ACCESS Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516678211?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:00","pubTimestamp":1741089600,"startTime":"0","endTime":"0","summary":"BRIDGEWATER, NJ / ACCESS Newswire / March 4, 2025 / Tharimmune, Inc.  , a clinical-stage biotechnology company focused on immunology and inflammation, today announced the expansion of its product pipeline with HS1940, a dual-target multispecific biologic engineered to bind to both Programmed Death-1  and Vascular Endothelial Growth Factor  receptors. Using its proprietary EpiClick Technology, a versatile multispecific antibody engineering platform, HS1940 represents a key expansion of Tharimmune's product pipeline and underscores the Company's commitment to addressing unmet needs.The Company has generated positive target engagement data showing that the biparatopic format expands therapeutic versatility compared with monospecific antibodies, which are limited to targeting a single epitope on a single receptor. As illustrated, the biparatopic antibody constructs effectively achieve target engagement on both PD-1 and VEGF. By engaging two distinct","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tharimmune-announces-positive-target-engagement-120000409.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU1169590202.USD","PBC","PD","BK4023","LU1169589451.USD","THAR"],"gpt_icon":0},{"id":"2514872123","title":"Zevia PBC Is Maintained at Market Perform by Telsey Advisory Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2514872123","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514872123?lang=en_us&edition=fundamental","pubTime":"2025-02-27 18:49","pubTimestamp":1740653340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ZVIA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 27, 2025 05:49 ET (10:49 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4177","PBC","ZVIA"],"gpt_icon":0},{"id":"2514823634","title":"Zevia PBC (ZVIA) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2514823634","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514823634?lang=en_us&edition=fundamental","pubTime":"2025-02-27 15:10","pubTimestamp":1740640221,"startTime":"0","endTime":"0","summary":"Net Sales: $39.5 million in Q4 2024, an increase of 4.4% compared to Q4 2023.Gross Margin: 49.2%, an increase of 850 basis points from 40.7% in Q4 2023.Net Loss: $6.8 million, an improvement from a net loss of $9.2 million in Q4 2023.Adjusted EBITDA: Negative $3.9 million, improved by $3 million compared to Q4 2023.Cash and Cash Equivalents: $30.7 million at the end of Q4 2024.Full Year Net Sales: $155.1 million, a decrease of 6.8% from 2023.Full Year Gross Margin: 46.4%, up from 44.9% in 2023.Full Year Net Loss: $23.8 million, improved from a net loss of $28.3 million in 2023.Store Expansion: Increased presence from 800 to over 4,300 Walmart locations.2025 Net Sales Guidance: Estimated between $158 million to $163 million.2025 Adjusted EBITDA Guidance: Expected between $8 million to $11 million.Zevia PBC  returned to top-line growth in Q4 2024 with a sales increase of over 4%, driven by increased volumes and expanded distribution.Despite the return to growth, Zevia PBC  reported a net","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zevia-pbc-zvia-q4-2024-071021955.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PBC","WMT","ZVIA"],"gpt_icon":1},{"id":"2514505844","title":"Q4 2024 Zevia PBC Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2514505844","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514505844?lang=en_us&edition=fundamental","pubTime":"2025-02-27 13:41","pubTimestamp":1740634873,"startTime":"0","endTime":"0","summary":"Amy Taylor; President, Chief Executive Officer, Director; Zevia PBC. Ladies and gentlemen, greetings and welcome to the ZVR PBC Q4 2024 earnings score.  As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Alex Lisin from ICR. Please go ahead.Thanks for joining us for our 4th quarter and full year 2024 conference call. We are pleased to have ended the year on a strong note with the return to top line growth and progress toward our goal of achieving profitability. We elevated our brand identity, advanced our three strategic growth pillars, and continued to lay the foundation for our plans for sustainable long-term growth and profitability. I want to thank the ZA team for their commitment and dedication to executing on these priorities. I am as confident as I have been since joining Zevia about our long-term opportunities. Our optimism in the future is based on three factors. First, the Better for you soda category is in the nascent stages, and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-2024-zevia-pbc-earnings-054113294.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PBC","ZVIA","WMT"],"gpt_icon":1},{"id":"2514898508","title":"Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2514898508","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514898508?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:01","pubTimestamp":1740603660,"startTime":"0","endTime":"0","summary":"- 2025 expected global net product sales of $420 million to $435 million. - VISTAS study of volixibat in PSC expected to complete enrollment in second half 2025; topline data expected 2026. - CTEXLI  approved in the US for cerebrotendinous xanthomatosis. - Conference call to provide business updates today, February 26 at 1:30 p.m. PT/4:30 p.m. ET. FOSTER CITY, Calif., February 26, 2025----Mirum Pharmaceuticals, Inc.  today reported financial results for the fourth quarter and year-end 2024 and provided a business update.\"2024 was another year of significant growth and accomplishments for Mirum and in 2025 we expect this momentum to continue,\" said Chris Peetz, chief executive officer of Mirum. \"We continue to expand the reach of our three commercial medicines within our patient communities and look forward to another year of strong financial performance. On top of this, we are looking forward to multiple upcoming clinical and regulatory milestones, such as PSC where we’re expecting ful","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-fourth-quarter-210100952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["X","BK4006","ALGS","IBAT","BK4505","FXS","PBC","ALT","MIRM","PSC","FSV","BSEP","BK4516","BK4588","BK4079","BK4139","BK4520","BK4599","LU1878469433.USD","BK4585","BK4532","GGT"],"gpt_icon":1}],"pageSize":16,"totalPage":9,"pageCount":2,"totalSize":141}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-12-30","symbol":"PBC","reason":null,"defaultRemindTime":1640874600000,"announcedDate":"2021-12-01","type":"delisting","dateTimestamp":1640840400000},{"market":"US","date":"2021-11-30","symbol":"PBC","amount":0.4296875,"defaultRemindTime":1638282600000,"name":"Prospect Capital Corp","recordDate":"2021-12-15","payableDate":"2021-12-01","currency":"USD","type":"dividend","dateTimestamp":1638248400000},{"market":"US","date":"2021-08-31","symbol":"PBC","amount":0.4296875,"defaultRemindTime":1630416600000,"name":"Prospect Capital Corp","recordDate":"2021-09-15","payableDate":"2021-09-01","currency":"USD","type":"dividend","dateTimestamp":1630382400000},{"market":"US","date":"2021-05-28","symbol":"PBC","amount":0.4296875,"defaultRemindTime":1622208600000,"name":"Prospect Capital Corp","recordDate":"2021-06-15","payableDate":"2021-06-01","currency":"USD","type":"dividend","dateTimestamp":1622174400000},{"market":"US","date":"2021-02-26","symbol":"PBC","amount":0.4296875,"name":"Prospect Capital Corp","recordDate":"2021-03-15","payableDate":"2021-03-01","currency":"USD","type":"dividend","dateTimestamp":1614315600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBC\",market:\"US\",,,undefined,":[{"executeDate":"2019-02-28","recordDate":"2019-03-01","paymentDate":"2019-03-15","value":0.4774306,"currency":"USD"},{"executeDate":"2019-08-29","recordDate":"2019-08-30","paymentDate":"2019-09-15","value":0.4296875,"currency":"USD"},{"executeDate":"2019-11-27","recordDate":"2019-11-29","paymentDate":"2019-12-15","value":0.4296875,"currency":"USD"},{"executeDate":"2020-02-27","recordDate":"2020-02-28","paymentDate":"2020-03-15","value":0.4296875,"currency":"USD"},{"executeDate":"2020-05-29","recordDate":"2020-06-01","paymentDate":"2020-06-15","value":0.4296875,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBC\",market:\"US\",delay:false,,,undefined,":{}}}